Innovation backed by scientific evidence

Setting new gold standards in neurodegenerative disorder assessment

Indivi is developing and validating user-friendly, reliable, and responsive measurement instruments spanning across all key concepts of interest (COI), focusing on Multiple Sclerosis, Parkinson's disease, Alzheimer’s disease, and related dementias.

A Unique Quality Control Embedded in the Data Science Pipeline

By bringing together Konectomᵀᴹ and dreaMSᴹᴰ, Indivi is able to offer a best-in-class digital measurement technology solution in Multiple Sclerosis, and Parkinson's disease, while developing innovative solutions for Alzheimer’s disease and related dementias.

A Unique Quality Control Embedded in the Data Science Pipeline

By bringing together Konectomᵀᴹ and dreaMSᴹᴰ, Indivi is able to offer a best-in-class digital measurement technology solution in Multiple Sclerosis, and Parkinson's disease, while developing innovative solutions for Alzheimer’s disease and related dementias.

A Unique Quality Control Embedded in the Data Science Pipeline

By bringing together Konectomᵀᴹ and dreaMSᴹᴰ, Indivi is able to offer a best-in-class digital measurement technology solution in Multiple Sclerosis, and Parkinson's disease, while developing innovative solutions for Alzheimer’s disease and related dementias.

Konectom

Indivi

Your end-to-end scientific research partner in advancing digital endpoints

Indivi is developing and validating user-friendly, reliable, and responsive instruments, spanning across key measurement concepts of interest (COI). By bringing together Konectomᵀᴹ (licensed from Biogen) and dreaMSᴹᴰ technologies, Indivi’s platform now includes bespoke instruments for additional COIs such as voice, keystroke dynamics and bradykinesia.

Indivi is developing and validating user-friendly, reliable, and responsive measurement instruments, spanning across key concepts of interest (COI). By bringing together Konectomᵀᴹ (licensed from Biogen) and dreaMSᴹᴰ technologies, Indivi’s platform now includes bespoke instruments for additional COIs such as voice, keystroke dynamics and bradykinesia.

Indivi is developing and validating user-friendly, reliable, and responsive measurement instruments, spanning across key concepts of interest (COI). By bringing together Konectomᵀᴹ (licensed from Biogen) and dreaMSᴹᴰ technologies, Indivi’s platform now includes bespoke instruments for additional COIs such as voice, keystroke dynamics and bradykinesia.

Movement

Cognition

Vision

Balance

Dexterity

Voice

Clinical trial platform for neurology

Indivi

App

One single data capture system combining assessments
from multiple partner devices and Apps.

Indivi

Cloud

Real time data transfer to our secured cloud,
with automated data integrity and quality checks

Indivi

PRO

Advanced clinical trial platform
for pharma industry, clinical research
organisations, and academia

Indivi and RC2NB

Pioneering the future of precision neurology

Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.

Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).

The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.

More about RC2NB

Indivi and RC2NB

Pioneering the future of precision neurology

Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.

Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).

The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.

More about RC2NB

Indivi and RC2NB

Pioneering the future of precision neurology

Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.

Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).

The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.

More about RC2NB